Humanigen Inc (HGENQ)

Humanigen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	10.16	70.02	67.74	0.21	0.89
Cash & Cash Equivalents	10.16	70.02	67.74	0.21	0.89
Cash Growth	-85.50%	3.36%	31552.80%	-75.82%	5.61%
Other Current Assets	0.95	0.96	0.48	0.24	0.41
Total Current Assets	11.11	70.97	68.21	0.45	1.3
Other Long-Term Assets	0.09	0.09	0.09	0.07	0.07
Total Long-Term Assets	0.09	0.09	0.09	0.07	0.07
Total Assets	11.2	71.06	68.3	0.52	1.37
Accounts Payable	40.52	44.7	15.37	5.05	2.86
Deferred Revenue	2.65	5.16	4.22	0	0
Current Debt	0	0	0	5.24	2.28
Other Current Liabilities	13.03	18.86	0.83	3.31	3.13
Total Current Liabilities	56.19	68.73	20.42	13.59	8.26
Long-Term Debt	0	25.01	0	1.25	1.22
Other Long-Term Liabilities	1.77	1.02	2.34	0	0
Total Long-Term Liabilities	1.77	26.02	2.34	1.25	1.22
Total Liabilities	57.96	94.75	22.76	14.84	9.48
Total Debt	0	25.01	0	6.49	3.5
Debt Growth	-	-	-	85.61%	-81.96%
Common Stock	635.04	587.39	419.98	270.58	266.49
Retained Earnings	-681.81	-611.08	-374.43	-284.9	-274.6
Shareholders' Equity	-46.77	-23.69	45.55	-14.32	-8.11
Net Cash / Debt	10.16	45.01	67.74	-6.27	-2.61
Net Cash / Debt Growth	-77.44%	-33.55%	-	-	-
Net Cash Per Share	0.11	0.77	1.83	-0.28	-0.14
Working Capital	-45.09	2.25	47.8	-13.14	-6.96
Book Value Per Share	-0.52	-0.41	1.23	-0.64	-0.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).